ATE469119T1 - Verfahren zur herstellung von polymorphen von sertralin hydrochlorid - Google Patents

Verfahren zur herstellung von polymorphen von sertralin hydrochlorid

Info

Publication number
ATE469119T1
ATE469119T1 AT04798397T AT04798397T ATE469119T1 AT E469119 T1 ATE469119 T1 AT E469119T1 AT 04798397 T AT04798397 T AT 04798397T AT 04798397 T AT04798397 T AT 04798397T AT E469119 T1 ATE469119 T1 AT E469119T1
Authority
AT
Austria
Prior art keywords
polymorphoes
producing
sertraline hydrochloride
sertraline
hydrochloride
Prior art date
Application number
AT04798397T
Other languages
English (en)
Inventor
Dharmaraj Rao
Rajendra Kankan
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Application granted granted Critical
Publication of ATE469119T1 publication Critical patent/ATE469119T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/82Purification; Separation; Stabilisation; Use of additives
    • C07C209/84Purification
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/39Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
    • C07C211/41Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
    • C07C211/42Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems with six-membered aromatic rings being part of the condensed ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT04798397T 2003-11-04 2004-11-04 Verfahren zur herstellung von polymorphen von sertralin hydrochlorid ATE469119T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1158MU2003 2003-11-04
PCT/GB2004/004672 WO2005047229A2 (en) 2003-11-04 2004-11-04 Process for the preparation of polymorphs of selective serotonin reuptake inhibitor

Publications (1)

Publication Number Publication Date
ATE469119T1 true ATE469119T1 (de) 2010-06-15

Family

ID=34586963

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04798397T ATE469119T1 (de) 2003-11-04 2004-11-04 Verfahren zur herstellung von polymorphen von sertralin hydrochlorid

Country Status (13)

Country Link
US (1) US7893300B2 (de)
EP (1) EP1682483B1 (de)
JP (1) JP4791970B2 (de)
KR (1) KR101161813B1 (de)
CN (1) CN1902157A (de)
AT (1) ATE469119T1 (de)
AU (1) AU2004289512A1 (de)
CA (1) CA2544684A1 (de)
DE (1) DE602004027401D1 (de)
NZ (1) NZ546902A (de)
RU (1) RU2376279C2 (de)
WO (1) WO2005047229A2 (de)
ZA (1) ZA200603502B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2984109B1 (de) * 2013-06-04 2019-09-25 Dow Global Technologies LLC Verfahren zur herstellung von lithiumcarboxymethylcellulose
CN112552188B (zh) * 2020-12-17 2023-07-28 山西仟源医药集团股份有限公司 盐酸舍曲林晶型i的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US5248699A (en) * 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
US5734083A (en) * 1996-05-17 1998-03-31 Torcan Chemical Ltd. Sertraline polymorph
BR9810403A (pt) * 1997-07-01 2000-08-29 Pfizer Sais da sertralina e formas de dosagem de liberação sustentada da sertralina
US6500987B1 (en) * 1998-11-27 2002-12-31 Teva Pharmaceutical Industries Ltd. Sertraline hydrochloride polymorphs
US6495721B1 (en) * 1999-08-09 2002-12-17 Teva Pharmaceutical Industries Ltd. Sertraline hydrochloride Form II and methods for the preparation thereof
TWI260315B (en) * 1999-10-29 2006-08-21 Ciba Sc Holding Ag Polymorphic forms of sertraline hydrochloride
IL150332A0 (en) * 1999-12-21 2002-12-01 Teva Pharma Novel sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them
EP1499581A1 (de) 2002-04-29 2005-01-26 Teva Pharmaceutical Industries Ltd. Verfahren zur herstellung der polymorphen form ii von sertralinhydrochlorid, pharmazeutische formulierungen und verfahren zur deren verabreichung

Also Published As

Publication number Publication date
ZA200603502B (en) 2008-02-27
CN1902157A (zh) 2007-01-24
KR101161813B1 (ko) 2012-07-05
US20070135524A1 (en) 2007-06-14
RU2376279C2 (ru) 2009-12-20
AU2004289512A2 (en) 2005-05-26
JP2007510640A (ja) 2007-04-26
RU2006119477A (ru) 2007-12-20
US7893300B2 (en) 2011-02-22
JP4791970B2 (ja) 2011-10-12
KR20060123234A (ko) 2006-12-01
EP1682483B1 (de) 2010-05-26
CA2544684A1 (en) 2005-05-26
DE602004027401D1 (de) 2010-07-08
EP1682483A2 (de) 2006-07-26
NZ546902A (en) 2010-02-26
AU2004289512A1 (en) 2005-05-26
WO2005047229A2 (en) 2005-05-26
WO2005047229A3 (en) 2005-07-07

Similar Documents

Publication Publication Date Title
ATE425136T1 (de) Verfahren zur herstellung substituierter 3-aryl- butyl-aminverbindungen
ATE529409T1 (de) Verfahren zur herstellung von kristallinen aripiprazolformen
DE602004031895D1 (de) Verfahren zur Herstellung von Dichlorpropanol
DE60323192D1 (de) Verfahren zur Herstellung von Hydroxyalkylstärkederivaten
DE602004010234D1 (de) Verfahren zur herstellung von 4-aminodiphenylamin
ATE501264T1 (de) Enzymatische verfahren zur herstellung 4- substituierter 3-hydroxybuttersäure-derivate
ATE354583T1 (de) Verfahren zur herstellung c-7 substituierter 5- androstene
DE50311721D1 (de) Verfahren zur Herstellung von Aryl-aminopropanolen
ATE424892T1 (de) Verfahren zur herstellung von derivaten des 4a,5, 9,10,11,12-hexahydrobenzofuro ä3a,3,2üä 2 ü- benzazepins
DE60210778D1 (de) Verfahren zur herstellung von 4-amino-2,5-bisheterocyclylchinazolinen
DE60322356D1 (de) Verfahren zur herstellung von 2-aminoindanderivaten
DE60335766D1 (de) Verfahren zur Herstellung von m-Xylylendiamin
DE60309847D1 (de) Zwischenprodukte und verfahren zur herstellung von heptapeptid-oxytocinanaloga
ATE469119T1 (de) Verfahren zur herstellung von polymorphen von sertralin hydrochlorid
ATE325794T1 (de) Verfahren zur herstellung und zwischenprodukte von pyridin-2-yl-amin
DE50211253D1 (de) Verfahren zur Herstellung von Makrokapseln
DE602004027840D1 (de) Verfahren zur herstellung von thiazolopyrimidinen
ATE496038T1 (de) Verfahren zur herstellung von quetiapin
DE60301444T2 (de) Verfahren zur Herstellung von Polyalkylphenoxyaminoalkanen
DE602004005239D1 (de) Verfahren zur herstellung von tubulininhibitoren
DE60302979D1 (de) Verfahren zur Herstellung von Epsilon-Caprolactone
DE502004011536D1 (de) verfahren zur herstellung von bengamide-derivaten
DE60324881D1 (de) Verfahren zur Herstellung von Polyalkylphenoxyaminoalkanen
DE60330749D1 (de) Verfahren zur herstellung von 7-alpha-methylsteroide
DE602004018447D1 (de) Verfahren zur Herstellung von Alkylbenzaldehyden

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties